Literature DB >> 25739323

Influence of NRGN rs12807809 polymorphism on symptom severity in individuals with schizophrenia in the Han population but not the Zhuang population of south China.

Li Su1, Jianxiong Long1, Runde Pan2, Xinfeng Xie2, Xixiang Mao2, Yang Zhou1, Qiang Chen2, Bo Wei1.   

Abstract

BACKGROUND: NRGN is one of the most promising candidate genes for schizophrenia based on function and position. Therefore, this study aimed to examine the genetic association of this polymorphism with schizophrenia in the Zhuang and Han populations of south China. Subjects and methods A total of 282 patients (188 Han and 94 Zhuang) and 282 healthy subjects (188 Han and 94 Zhuang) were recruited. Of these, 246 schizophrenia patients underwent an assessment of psychotic symptoms using the Positive and Negative Syndrome Scale (PANSS). A TaqMan genotyping assay method was used to determine the genotypes.
RESULTS: We did not find a significant association of rs12807809 polymorphism with schizophrenia in the total pooled samples, or in the separate ethnic groups. However, in Han schizophrenia patients, quantitative data analyses showed that the CC genotype of the rs12807809 polymorphism was associated with PANSS aggression subscale score and activation subscale score. Furthermore, carriers of the C allele of rs12807809 polymorphism among Han schizophrenia patients had higher scores of general, activation, depression, aggression, and global symptoms than the T allele carriers.
CONCLUSION: In conclusion rs12807809 polymorphism may not contribute to the risk of schizophrenia but influence the clinical symptoms of schizophrenia in the Han population.

Entities:  

Keywords:  NRGN; polymorphism; rs12807809; schizophrenia

Mesh:

Substances:

Year:  2015        PMID: 25739323     DOI: 10.1017/neu.2015.13

Source DB:  PubMed          Journal:  Acta Neuropsychiatr        ISSN: 0924-2708            Impact factor:   3.403


  5 in total

1.  Genetic variation in the 3'-untranslated region of PAK1 influences schizophrenia susceptibility.

Authors:  Juan Jiang; Jianxiong Long; Weijun Ling; Guifeng Huang; Li Su
Journal:  Exp Ther Med       Date:  2017-01-12       Impact factor: 2.447

2.  Neurogranin regulates sensorimotor gating through cortico-striatal circuitry.

Authors:  John M Sullivan; Caleb A Grant; Ashlie N Reker; Lailun Nahar; Nicholas E Goeders; Hyung W Nam
Journal:  Neuropharmacology       Date:  2019-03-19       Impact factor: 5.250

3.  Association between NRGN gene polymorphism and resting-state hippocampal functional connectivity in schizophrenia.

Authors:  Yifan Zhang; Xiaohong Gong; Zhiyang Yin; Lingling Cui; Jian Yang; Pengshuo Wang; Yifang Zhou; Xiaowei Jiang; Shengnan Wei; Fei Wang; Yanqing Tang
Journal:  BMC Psychiatry       Date:  2019-04-05       Impact factor: 3.630

4.  Neurogranin regulates eNOS function and endothelial activation.

Authors:  Vino T Cheriyan; Mabruka Alfaidi; Ashton N Jorgensen; Md Ashiqul Alam; Chowdhury S Abdullah; Gopi K Kolluru; Md Shenuarin Bhuiyan; Christopher G Kevil; A Wayne Orr; Hyung W Nam
Journal:  Redox Biol       Date:  2020-03-05       Impact factor: 11.799

5.  The association between rs12807809 polymorphism in neurogranin gene and risk of schizophrenia: A meta-analysis.

Authors:  Lu Jin; Zhiguo An; Bin Xu; Daibin Mu; Songnian Fu; Hongxing Hu; Yongyong Shi; Xiao Luo; Qizhong Yi
Journal:  Medicine (Baltimore)       Date:  2019-12       Impact factor: 1.889

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.